Literature DB >> 1433087

Long term use of transcutaneous electrical nerve stimulation at Newcastle Pain Relief Clinic.

M I Johnson1, C H Ashton, J W Thompson.   

Abstract

This retrospective study of long-term use of transcutaneous electrical nerve stimulation (TENS) at Newcastle Pain Relief Clinic indicates that TENS has been a successful analgesic treatment for 58.6% of 1582 patients attending the clinic over a period of 10 years. A wide range of pain conditions were found to respond to TENS and many patients continued to use the treatment for several years. Most patients not responding to TENS (during a home trial) returned stimulators at the first follow-up appointment. Thus TENS should be considered as a simple, safe and reusable first line treatment for many pain conditions.

Entities:  

Mesh:

Year:  1992        PMID: 1433087      PMCID: PMC1294602          DOI: 10.1177/014107689208500508

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  4 in total

1.  An in-depth study of long-term users of transcutaneous electrical nerve stimulation (TENS). Implications for clinical use of TENS.

Authors:  M I Johnson; C H Ashton; J W Thompson
Journal:  Pain       Date:  1991-03       Impact factor: 6.961

2.  Transcutaneous electrical nerve stimulation for chronic pain.

Authors:  J A Bates; P W Nathan
Journal:  Anaesthesia       Date:  1980-08       Impact factor: 6.955

3.  A controlled trial of transcutaneous electrical nerve stimulation (TENS) and exercise for chronic low back pain.

Authors:  R A Deyo; N E Walsh; D C Martin; L S Schoenfeld; S Ramamurthy
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

4.  Long term results of peripheral conditioning stimulation as an analgesic measure in chronic pain.

Authors:  Margareta B E Eriksson; Bengt H Sjölund; Sören Nielzén
Journal:  Pain       Date:  1979-06       Impact factor: 6.961

  4 in total
  9 in total

1.  Long-term use of transcutaneous electrical stimulation.

Authors:  A E Lyons
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 5.344

2.  [Analgesic efficacy of TENS therapy in patients with gonarthrosis. A prospective, randomised, placebo-controlled, double-blind study].

Authors:  B Gschiel; H Kager; W Pipam; K Weichart; R Likar
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

3.  Spinal 5-HT(2) and 5-HT(3) receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats.

Authors:  Rajan Radhakrishnan; Ellen W King; Janelle K Dickman; Carli A Herold; Natalie F Johnston; Megan L Spurgin; Kathleen A Sluka
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

Review 4.  Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.

Authors:  Mark I Johnson; Leica S Claydon; G Peter Herbison; Gareth Jones; Carole A Paley
Journal:  Cochrane Database Syst Rev       Date:  2017-10-09

5.  Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats.

Authors:  R Radhakrishnan; K A Sluka
Journal:  Neuropharmacology       Date:  2003-12       Impact factor: 5.250

6.  The effect of transcutaneous electrical nerve stimulation (TENS) on autonomic cardiovascular reflexes.

Authors:  J E Sanderson; B Tomlinson; M S Lau; K W So; A H Cheung; J A Critchley; K S Woo
Journal:  Clin Auton Res       Date:  1995-04       Impact factor: 4.435

7.  Analgesic effects of transcutaneous electrical nerve stimulation and interferential current on experimental ischemic pain models: frequencies of 50 hz and 100 hz.

Authors:  Young-Hyeon Bae; Suk Min Lee
Journal:  J Phys Ther Sci       Date:  2014-12-25

Review 8.  Transcutaneous Electrical Nerve Stimulation (TENS) for Primary Dysmenorrhea: An Overview.

Authors:  Michal Elboim-Gabyzon; Leonid Kalichman
Journal:  Int J Womens Health       Date:  2020-01-08

9.  Transcutaneous electrical nerve stimulation for the management of tennis elbow: a pragmatic randomized controlled trial: the TATE trial (ISRCTN 87141084).

Authors:  Linda S Chesterton; Daniëlle A van der Windt; Julius Sim; Martyn Lewis; Christian D Mallen; Elizabeth E Mason; Catherine Warlow; Kanchan Vohora; Elaine M Hay
Journal:  BMC Musculoskelet Disord       Date:  2009-12-11       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.